We are live on ! Find out more
GX

Greylock XII Portfolio holdings

AUM $51.9M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
-28.48%
1 Year Est. Return
-11.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.2M
AUM Growth
-$6.49M
Cap. Flow
-$441K
Cap. Flow %
-2.91%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LRMR icon
Larimar Therapeutics
LRMR
+$441K

Sector Composition

Rank Sector Weight
1 Communication Services 100%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
1
DELISTED
Twitter, Inc.
TWTR
$15.2M 100%
917,227
LRMR icon
2
Larimar Therapeutics
LRMR
$421M
-5,847
Closed -$441K

Similar funds

Greylock XII's Q1 2016 Portfolio in Review

As of Q1 2016, Greylock XII held 2 positions worth $15.2M, down 30% from $21.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greylock XII's Q1 2016 filing shows 1 closed position. The largest sale was Larimar Therapeutics, an estimated $441K.

By sector, the portfolio is most concentrated in Communication Services at 100% of assets, up from 98% a quarter earlier, followed by Healthcare.

  • Greylock XII fully exited Larimar Therapeutics in Q1 2016, selling an estimated $441K.
  • Greylock XII's ten largest holdings make up 100% of its $15.2M portfolio in Q1 2016.
  • Greylock XII opened 0 new positions and closed 1 in Q1 2016.
  • Greylock XII's portfolio value fell 30% quarter-over-quarter to $15.2M.

Based on Greylock XII's 13F filing for Q1 2016, filed 22 Apr 2016.